4th Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$2,670,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

International tax issues, including: Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts Innovation/Patent Box Innovation Promotion Act of 2015 - Discussion Draft Tax Extenders, R&D Tax Credit, S.1946 Tax Relief Extension Act

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
NANCY ELLEN MCCARTHY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1946 (114th)

Copyright/Patent/Trademark CPT

H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 632 (114th), S. 2019 (114th), H.R. 9 (114th), S. 1137 (114th)

Health Issues HCR

Biosimilars, no specific bill Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill FDA Reform, H.R. 6, 21st Century Cures H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3678 (114th), H.R. 6 (114th)

Medicare/Medicaid MMM

End Stage Renal Disease and issues related to dialysis Medicare Part B (Average Sales Price) and Medicare Part D drug reimbursement issues Coding and reimbursement for oncology drugs/biologics

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
RUTH HOFFMAN —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.